key: cord-1017164-lsl601vf
authors: Marcano, Andrew; Nanduri, Ananya; SALEEM, TAHMINA; Bonk, Michael
title: ATYPICAL PAROTITIS AS A RESULT OF SEVERE COVID-19 INFECTION
date: 2021-10-31
journal: Chest
DOI: 10.1016/j.chest.2021.07.319
sha: 61038785675a53ab2bc4ddf8601d5c4e0e7d0e01
doc_id: 1017164
cord_uid: lsl601vf

TOPIC: Chest Infections TYPE: Medical Student/Resident Case Reports INTRODUCTION: Parotitis occurs in extremes of age and is associated with infections or inflammatory conditions. Typical bacterial parotitis presents with a unilateral, tender enlarged parotid gland and fever whereas inflammatory parotitis presents with bilateral enlargement of the parotids without fever. Here, we present two atypical cases: bilateral parotitis likely secondary to bacterial infection and unilateral parotitis likely due to inflammation. CASE PRESENTATION: We present a 45-year-old male with history of obesity who presented with hypoxia and dyspnea. CT angiogram noted multifocal pneumonia, consistent with COVID-19. He was started on dexamethasone, remdesivir and baricitinib as well as community acquired pneumonia coverage. On day 5, he was placed on high-flow nasal cannula due to progressive hypoxia. Although initially afebrile, he developed a fever on day 12, with tachypnea and tachycardia. Acute swelling of the submandibular space with adjacent erythema and a lactic acid of 3.2 were noted. CT neck demonstrated enlarged parotid glands bilaterally with inflammatory changes indicative of parotitis, no abscess or mass was noted. He was started on vancomycin, with improvement of his erythema and swelling within 3 days. Blood cultures were positive for MSSA. Patient continued to deteriorate, requiring intubation on day 18 and died on day 34.The second case is a 79-year-old-male with history of COPD on 3L and type 2 diabetes mellitus who presented with hypercapnic respiratory failure, found to be COVID-19 positive. The patient required non-invasive ventilation for progressive respiratory failure, despite COVID-19 treatment. He developed a sudden swelling of the right mandibular area on day 7 of admission. CT neck identified an enlarged heterogenous enhancement of the right parotid gland and edema consistent with parotitis. Blood cultures were negative. The patient was started on vancomycin but had worsening oxygen requirements and encephalopathy, was ultimately made DNR and expired on day 9. DISCUSSION: There has been increased incidence of atypical disease presentation and reactivation of latent infections during the COVID-19 pandemic. In the above patients, parotitis occurred secondary to severe viral illness, immune suppression, increased inflammation and/or superimposed bacterial infection. COVID-19 has been shown to cause significant inflammatory response and immunosuppression with lymphopenia, thrombocytopenia and low complement levels. Both patients had elevated inflammatory markers and persistent leukopenia. CONCLUSIONS: The pathophysiology of atypical parotitis and other atypical disease presentations, in the setting of severe COVID-19, should further be investigated. REFERENCE #1: Tian W, Zhang N, Jin R, et al. Immune suppression in the early stage of COVID-19 disease. Nat Commun. 2020;11(1):5859. Published 2020 Nov 17. doi:10.1038/s41467-020-19706-9 REFERENCE #2: Fisher J, Monette DL, Patel KR, Kelley BP, Kennedy M. COVID-19 associated parotitis. Am J Emerg Med. 2021;39:254.e1-254.e3. doi:10.1016/j.ajem.2020.06.059 REFERENCE #3: Wilson M, Pandey S. Parotitis. [Updated 2020 Dec 19]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing;2021 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK560735/ DISCLOSURES: No relevant relationships by Michael Bonk, source=Web Response No relevant relationships by Andrew Marcano, source=Web Response No relevant relationships by Ananya Nanduri, source=Web Response No relevant relationships by TAHMINA SALEEM, source=Web Response

INTRODUCTION: Parotitis occurs in extremes of age and is associated with infections or inflammatory conditions. Typical bacterial parotitis presents with a unilateral, tender enlarged parotid gland and fever whereas inflammatory parotitis presents with bilateral enlargement of the parotids without fever. Here, we present two atypical cases: bilateral parotitis likely secondary to bacterial infection and unilateral parotitis likely due to inflammation.

We present a 45-year-old male with history of obesity who presented with hypoxia and dyspnea. CT angiogram noted multifocal pneumonia, consistent with COVID-19. He was started on dexamethasone, remdesivir and baricitinib as well as community acquired pneumonia coverage. On day 5, he was placed on high-flow nasal cannula due to progressive hypoxia. Although initially afebrile, he developed a fever on day 12, with tachypnea and tachycardia. Acute swelling of the submandibular space with adjacent erythema and a lactic acid of 3.2 were noted. CT neck demonstrated enlarged parotid glands bilaterally with inflammatory changes indicative of parotitis, no abscess or mass was noted. He was started on vancomycin, with improvement of his erythema and swelling within 3 days. Blood cultures were positive for MSSA. Patient continued to deteriorate, requiring intubation on day 18 and died on day 34.The second case is a 79-year-old-male with history of COPD on 3L and type 2 diabetes mellitus who presented with hypercapnic respiratory failure, found to be COVID-19 positive. The patient required non-invasive ventilation for progressive respiratory failure, despite COVID-19 treatment. He developed a sudden swelling of the right mandibular area on day 7 of admission. CT neck identified an enlarged heterogenous enhancement of the right parotid gland and edema consistent with parotitis. Blood cultures were negative. The patient was started on vancomycin but had worsening oxygen requirements and encephalopathy, was ultimately made DNR and expired on day 9.

DISCUSSION: There has been increased incidence of atypical disease presentation and reactivation of latent infections during the COVID-19 pandemic. In the above patients, parotitis occurred secondary to severe viral illness, immune suppression, increased inflammation and/or superimposed bacterial infection. COVID-19 has been shown to cause significant inflammatory response and immunosuppression with lymphopenia, thrombocytopenia and low complement levels. Both patients had elevated inflammatory markers and persistent leukopenia.

The pathophysiology of atypical parotitis and other atypical disease presentations, in the setting of severe COVID-19, should further be investigated.

Immune suppression in the early stage of COVID-19 disease

COVID-19 associated parotitis

StatPearls [Internet